MindMed
NY - New YorkBiotechnology
Focus: MindMed is a biotech company developing psychedelic-inspired drugs targeting psychiatric disorders. The company operates as a clinical-stage innovator in an emerging therapeutic category.
Profile data last refreshed 14m ago · AI intelligence enriched 2w ago
Open Jobs
21+9 this month
Growing — net +9 jobs in 30d
17 jobs added vs 8 removed. Steady team buildout.
Should You Work at MindMed?
AI assessmentBest suited for early-stage believers willing to tolerate execution risk in exchange for exposure to a novel therapeutic class.
Why Work Here
- Ground-floor opportunity in psychedelics, an emerging therapeutic paradigm gaining FDA and institutional attention
- Clinical Science is actively hiring (5 roles), signaling pipeline advancement and execution focus
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for MindMed
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.